In 2011, Optimer® began marketing DIFICID® (fidaxomicin) tablets, the first FDA approved treatment for Clostridium difficile-associated diarrhea (CDAD) in more than 25 years. The launch of DIFICID was successful due to the commitment and excellence of our employees. We understand that continued success will always depend on our employees, and Optimer aspires to be an employer of choice for professionals pursuing excellence and who share in our mission to develop and commercialize innovative hospital specialty products that have a positive impact on society.
Optimer’s headquarters are in Jersey City, New Jersey and we also have an office in San Diego, California. Optimer has a wholly owned subsidiary, Optimer Canada, located in Toronto that is responsible for the commercialization of DIFICID (fidaxomicin) tablets in Canada. We have about 300 employees dedicated to bettering the lives of patients and reducing the burden of disease. We aim to provide employees with a professional environment in which to grow and thrive and offer competitive benefits, professional growth opportunities, and the tools and resources to perform duties effectively and efficiently.
We offer a comprehensive benefits package: